Latest Breaking News On - Drug product - Page 6 : comparemela.com

Petros Pharmaceuticals, Inc : Petros Pharmaceuticals Announces Two Upcoming FDA Meetings to Review Progress and Path Forward for STENDRA Rx-to-OTC Switch

Petros Pharmaceuticals, Inc : Petros Pharmaceuticals Announces Two Upcoming FDA Meetings to Review Progress and Path Forward for STENDRA Rx-to-OTC Switch
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Stefan klotterJules abrahamPetros pharmaceuticalsAuxilium pharmaceuticalsSecurities exchangeDrug administrationEndo pharmaceuticalsPetros pharmaceuticals incExchange commissionImportant safety informationDrug productAdditional conditionNonprescription useSummative human factorsFady boctorChief commercial

Petros Pharmaceuticals (PTPI) Announces Two Upcoming FDA Meetings to Review Progress and Path Forward for STENDRA

Petros Pharmaceuticals (PTPI) Announces Two Upcoming FDA Meetings to Review Progress and Path Forward for STENDRA
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Petros pharmaceuticals incDrug administrationPetros pharmaceuticalsImportant safety informationDrug productAdditional conditionNonprescription useSummative human factorsFady boctorChief commercial

Petros Pharmaceuticals Announces Two Upcoming FDA Meetings to Review Progress and Path Forward for S

FDA requests meeting to review the Company's technology component and discuss further development and requirementsNEW YORK, NY / ACCESSWIRE / January 24, 2024 / Petros Pharmaceuticals, Inc. (NASDAQ:PTPI), a company focused on expanding consumer access to medication through over-the- counter (OTC) drug development pr.

Jules abrahamDrug administrationPetros pharmaceuticalsPetros pharmaceuticals incEndo pharmaceuticalsExchange commissionSecurities exchangeAuxilium pharmaceuticalsImportant safety informationDrug productAdditional conditionNonprescription useSummative human factorsFady boctorChief commercialDrug facts label

GenSight Biologics Provides Business and Financial Update

GenSight Biologics Provides Business and Financial Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomFrance generalThomas gidoinGensight biologicsGensight biologics euronextGuillaume van renterghemRegulatory agencyUniversity of pittsburgh school medicineParis vision instituteScientific adviceDrug substanceDrug productSight biologicsAlain sahelPittsburgh schoolFounding director

Agno Pharma snaps up Particle Sciences to beef up drug product formulation

The US contract development and manufacturing organization (CDMO) Agno Pharma has taken over compatriot firm Lubrizol Particle Sciences to increase its drug product formulation offerings.

United statesParticle sciencesSterling pharma solutionsPartners groupParticle scienceSnapdragon chemistryClinical developmentDrug deliveryLinical evolutionDrug productDrug development